Neurosense Therapeutics Eulerpool Haberleri

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Hisse Haberleri

Neurosense Therapeutics, dünya çapında birçok gazeteci ve yatırımcı tarafından takip edilmektedir. En güncel Neurosense Therapeutics haberlerini burada bir araya getiriyoruz.

• 16 Ağustos ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• 7 Ağustos ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• 7 Ağustos ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• 1 Ağustos ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• 1 Ağustos ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• 1 Ağustos ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• 9 Temmuz ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• 1 Temmuz ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• 27 Haziran ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• 24 Haziran ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results